18 April 2019

In The European respiratory journal Jakko van Ingen and Sanne Zweijpfenning showed that 40% of patients diagnosed with nontuberculous mycobacterial pulmonary disease also meet diagnostic criteria for chronic pulmonary aspergillosis.

In their cohort of patients with nontuberculous mycobacterial pulmonary disease, 60% of patients had positive Aspergillus IgG serology and 40% had both positive serology as well as positive cultures for Aspergillus fumigatus, an important fungal pathogen. Importantly, patients who proved Aspergillus IgG-positive had significantly poorer outcomes of treatment for their mycobacterial disease. In vitro, culture supernatants of Mycobacterium avium, the most frequent nontuberculous mycobacterium causing disease in the Netherlands, enhanced the growth of Aspergillus fumigatus. These two might truly behave like Bonnie and Clyde.

publication
Nontuberculous mycobacterial pulmonary disease and Aspergillus co-infection: Bonnie and Clyde?
Geurts K, Zweijpfenning SMH, Pennings LJ, Schildkraut JA, Boeree MJ, Magis-Escurra C, van der Lee H, Verweij PE, Hoefsloot W, van Ingen J.

Jakko van Ingen and Sanne Zweijpfenning are members theme Infectious diseases and global health.

Related news items


NIH grant for follow-up research on tuberculous meningitis

10 February 2022

Met subsidie van het Amerikaanse NIH gaat With a grant from the U.S. NIH, Reinout van Crevel will continue to unravel the disease process of tuberculous meningitis.

read more

Rob Aarnoutse is appointed as professor in Translation pharmacology of antimicrobial agents in particular drugs for tuberculosis

25 January 2021

Hospital pharmacist and clinical pharmacologist Rob Aarnoutse is appointed as professor in ‘Translation pharmacology of antimicrobial agents, in particular drugs for tuberculosis’ at Radboud University / Radboudumc, starting 16 November 2020.

read more

Minocycline to treat pulmonary Mycobacterium avium complex disease

9 May 2019

In Journal of Antimicrobial Chemotherapy Mike Ruth, Jakko van Ingen and colleagues showed that minocycline may be useful to treat pulmonary diseases caused by Mycobacterium avium complex bacteria. This is important as few drugs are active against this disease and treatment outcomes are very poor.

read more

ESCMID award for groundbreaking studies on NTM disease

18 April 2019

Jakko van Ingen received the ESCMID Young Investigator Award for his groundbreaking work on nontuberculous mycobacterial disease.

read more

International grants for tuberculous meningitis research

27 March 2019

Meningitis is the most deadly manifestation of tuberculosis. Two grants have been awarded to Radboudumc researchers.

read more

Optimizing high-dose rifampicin against tuberculosis

7 February 2019

In the American Journal of Respiratory and Critical Care Medicine Lindsey te Brake and colleagues described the shortcomings of a moderate increase in rifampicin dosing.

read more